In breast cancer, Epsin 3 (EPN3) can enhance E-cadherin endocytosis, activate β-catenin/TCF4-mediated EMT and promote the autocrine loop mediated by TGFβ, and ultimately promote metastasis of breast cancer cell. This evidence concerns the gene EPN3 and breast carcinoma.